These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

484 related items for PubMed ID: 11965534

  • 1. Human survivin is negatively regulated by wild-type p53 and participates in p53-dependent apoptotic pathway.
    Mirza A, McGuirk M, Hockenberry TN, Wu Q, Ashar H, Black S, Wen SF, Wang L, Kirschmeier P, Bishop WR, Nielsen LL, Pickett CB, Liu S.
    Oncogene; 2002 Apr 18; 21(17):2613-22. PubMed ID: 11965534
    [Abstract] [Full Text] [Related]

  • 2. DNA damage induces a novel p53-survivin signaling pathway regulating cell cycle and apoptosis in acute lymphoblastic leukemia cells.
    Zhou M, Gu L, Li F, Zhu Y, Woods WG, Findley HW.
    J Pharmacol Exp Ther; 2002 Oct 18; 303(1):124-31. PubMed ID: 12235242
    [Abstract] [Full Text] [Related]

  • 3. Inhibition of survivin reduces cell proliferation and induces apoptosis in human endometrial cancer.
    Ai Z, Yin L, Zhou X, Zhu Y, Zhu D, Yu Y, Feng Y.
    Cancer; 2006 Aug 15; 107(4):746-56. PubMed ID: 16826583
    [Abstract] [Full Text] [Related]

  • 4. Survivin gene expression is negatively regulated by the p53 tumor suppressor gene in non-small cell lung cancer.
    Nakano J, Huang CL, Liu D, Ueno M, Sumitomo S, Yokomise H.
    Int J Oncol; 2005 Nov 15; 27(5):1215-21. PubMed ID: 16211215
    [Abstract] [Full Text] [Related]

  • 5. Tumor-specific adenovirus-mediated PUMA gene transfer using the survivin promoter enhances radiosensitivity of breast cancer cells in vitro and in vivo.
    Wang R, Wang X, Li B, Lin F, Dong K, Gao P, Zhang HZ.
    Breast Cancer Res Treat; 2009 Sep 15; 117(1):45-54. PubMed ID: 18791823
    [Abstract] [Full Text] [Related]

  • 6. Development and validation of sensitive assays to quantitate gene expression after p53 gene therapy and paclitaxel chemotherapy using in vivo dosing in tumor xenograft models.
    Wen SF, Xie L, McDonald M, DiGiacomo R, Chang A, Gurnani M, Shi B, Liu S, Indelicato SR, Hutchins B, Nielsen LL.
    Cancer Gene Ther; 2000 Nov 15; 7(11):1469-80. PubMed ID: 11129289
    [Abstract] [Full Text] [Related]

  • 7. Induction of p53-regulated genes in lung cancer cells: implications of the mechanism for adenoviral p53-mediated apoptosis.
    Gu J, Zhang L, Swisher SG, Liu J, Roth JA, Fang B.
    Oncogene; 2004 Feb 12; 23(6):1300-7. PubMed ID: 14676844
    [Abstract] [Full Text] [Related]

  • 8. Association of p53 gene alterations with the expression of antiapoptotic survivin splice variants in breast cancer.
    Végran F, Boidot R, Oudin C, Defrain C, Rebucci M, Lizard-Nacol S.
    Oncogene; 2007 Jan 11; 26(2):290-7. PubMed ID: 16847456
    [Abstract] [Full Text] [Related]

  • 9. A SNP in the flt-1 promoter integrates the VEGF system into the p53 transcriptional network.
    Menendez D, Krysiak O, Inga A, Krysiak B, Resnick MA, Schönfelder G.
    Proc Natl Acad Sci U S A; 2006 Jan 31; 103(5):1406-11. PubMed ID: 16432214
    [Abstract] [Full Text] [Related]

  • 10. Identification of fractalkine, a CX3C-type chemokine, as a direct target of p53.
    Shiraishi K, Fukuda S, Mori T, Matsuda K, Yamaguchi T, Tanikawa C, Ogawa M, Nakamura Y, Arakawa H.
    Cancer Res; 2000 Jul 15; 60(14):3722-6. PubMed ID: 10919640
    [Abstract] [Full Text] [Related]

  • 11. Persistent activation of stat3 signaling induces survivin gene expression and confers resistance to apoptosis in human breast cancer cells.
    Gritsko T, Williams A, Turkson J, Kaneko S, Bowman T, Huang M, Nam S, Eweis I, Diaz N, Sullivan D, Yoder S, Enkemann S, Eschrich S, Lee JH, Beam CA, Cheng J, Minton S, Muro-Cacho CA, Jove R.
    Clin Cancer Res; 2006 Jan 01; 12(1):11-9. PubMed ID: 16397018
    [Abstract] [Full Text] [Related]

  • 12. p53 upregulates death receptor 4 expression through an intronic p53 binding site.
    Liu X, Yue P, Khuri FR, Sun SY.
    Cancer Res; 2004 Aug 01; 64(15):5078-83. PubMed ID: 15289308
    [Abstract] [Full Text] [Related]

  • 13. Caspase-1 activator Ipaf is a p53-inducible gene involved in apoptosis.
    Sadasivam S, Gupta S, Radha V, Batta K, Kundu TK, Swarup G.
    Oncogene; 2005 Jan 20; 24(4):627-36. PubMed ID: 15580302
    [Abstract] [Full Text] [Related]

  • 14. The proliferation-associated early response gene p22/PRG1 is a novel p53 target gene.
    Schäfer H, Trauzold A, Sebens T, Deppert W, Fölsch UR, Schmidt WE.
    Oncogene; 1998 May 14; 16(19):2479-87. PubMed ID: 9627114
    [Abstract] [Full Text] [Related]

  • 15. Transcriptional repression of the anti-apoptotic survivin gene by wild type p53.
    Hoffman WH, Biade S, Zilfou JT, Chen J, Murphy M.
    J Biol Chem; 2002 Feb 01; 277(5):3247-57. PubMed ID: 11714700
    [Abstract] [Full Text] [Related]

  • 16. Distinct expression of Survivin splice variants in breast carcinomas.
    Vegran F, Boidot R, Oudin C, Riedinger JM, Lizard-Nacol S.
    Int J Oncol; 2005 Oct 01; 27(4):1151-7. PubMed ID: 16142334
    [Abstract] [Full Text] [Related]

  • 17. Histone deacetylase 5 is not a p53 target gene, but its overexpression inhibits tumor cell growth and induces apoptosis.
    Huang Y, Tan M, Gosink M, Wang KK, Sun Y.
    Cancer Res; 2002 May 15; 62(10):2913-22. PubMed ID: 12019172
    [Abstract] [Full Text] [Related]

  • 18. Induction of Fas-mediated apoptosis in p53-transfected human colon carcinoma cells.
    Tamura T, Aoyama N, Saya H, Haga H, Futami S, Miyamoto M, Koh T, Ariyasu T, Tachi M, Kasuga M.
    Oncogene; 1995 Nov 16; 11(10):1939-46. PubMed ID: 7478511
    [Abstract] [Full Text] [Related]

  • 19. Topoisomerase IIalpha gene expression is regulated by the p53 tumor suppressor gene in nonsmall cell lung carcinoma patients.
    Liu D, Huang CL, Kameyama K, Hayashi E, Yamauchi A, Sumitomo S, Yokomise H.
    Cancer; 2002 Apr 15; 94(8):2239-47. PubMed ID: 12001123
    [Abstract] [Full Text] [Related]

  • 20. Global transcriptional program of p53 target genes during the process of apoptosis and cell cycle progression.
    Mirza A, Wu Q, Wang L, McClanahan T, Bishop WR, Gheyas F, Ding W, Hutchins B, Hockenberry T, Kirschmeier P, Greene JR, Liu S.
    Oncogene; 2003 Jun 05; 22(23):3645-54. PubMed ID: 12789273
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 25.